Everolimus brand names
WebApr 4, 2024 · Everolimus. Generic name: everolimus. Brand names: Afinitor, Afinitor Disperz, Zortress. Dosage form: oral tablet, tablet for oral suspension. Drug classes: … WebFeb 26, 2024 · Everolimus is available as tablets of 0.25, 0.50 and 0.75 mg under the brand name of Zortress for management of solid organ transplantation, and as tablets of 2.5, 5, 7.5 and 10 mg under the brand …
Everolimus brand names
Did you know?
Webeverolimus systemic. Brand names: Afinitor, Afinitor Disperz, Zortress. Drug classes: mTOR inhibitors, selective immunosuppressants. Everolimus systemic is used in the treatment of: Brain Tumor. Breast Cancer. … WebTacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug.After allogenic organ transplant, the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given. The drug can also be sold as a topical medication in the treatment of T-cell-mediated diseases such as eczema and …
WebDec 12, 2024 · Brand Names: US. Afinitor; Afinitor Disperz; Zortress. Brand Names: Canada. Afinitor; Afinitor Disperz; PMS-Everolimus; SANDOZ Everolimus; TEVA … Web20 rows · Everolimus Brand Names. Everolimus is available under the following different brand names: ...
WebJun 13, 2024 · Everolimus is also known by the brand names Afinitor and Zortress. It is an antineoplastic (anti-cancer) drug that belongs to a class called mTOR kinase inhibitors. Everolimus is a type of chemotherapy that prevents cancer cells from multiplying and restricts their growth. WebFeb 2, 2024 · ShowAll Page 1 Page 1 EVEROLIMUS ORAL CHEMOTHERAPY EDUCATION Name of your medication Generic name — everolimus eh-veh-ROH-lih-mus Brand name — Afinitor® a-FIN-i-tor Approved uses Everolimus is used to treat the following: o Hormone receptor–positive HR+ human epidermal growth factor receptor-2 …
WebRolimus Everolimus 10mg Tablet, Cipla, 10 Tablets In 1 Strip. ₹ 5,300/ Stripe Get Latest Price. Packaging Size: 10 tablets in 1 strip. Brand: Rolimus 10 Tablet. Composition: Everolimus (10mg) Manufacturer: Cipla. Treatment: Treatment of Breast cancer Pancreatic cancer, Lung cancer, Kidney Cancer. Manufactured By: Cipla Ltd.
WebUntil now, only the drug company Novartis exclusively made everolimus, which is sold under the brand name of Afinitor®. Afinitor is available both as tablets in strengths of 2.5 mg, 5 mg, 7.5 mg and 10 mg meant to be taken whole and as Afinitor Disperz®, which comes as 2 mg, 3 mg and 5 mg tablets to be taken after being dissolved in water ... show flamenco cdmxWebAt present, everolimus is available under the brand name drug Afinitor, sold by Novartis. The everolimus cost of treatment in the United States may exceed $10,000 per month, whereas the everolimus cost in Canada is roughly half that much due to differences in prescription drug coverage. show flagged items outlookWebTrade Names/Brand Names of Everolimus. India- Certican Tab. International- Afinitor, Zortress. Advertisement ... Drug Price List - Brand Names; Manforce (100 mg) A kare; Evion 400; show flash dir flash 違いWebAFINITOR® (everolimus) Tablets has delivered efficacy and safety data backed by more than a decade of clinical use. 1 First approved by the FDA in 2009 1, the figures speak for themselves: Over 7501 published articles 2; Over 1257 clinical trials 3; Over 1.1 million packs distributed 4; Novartis supports patients through access to a variety of financial, … show flakedWebProduct type: Generic (Rx), Dosage: Tablet, Strength: 10 mg, ActiveIngredient: Please view the product monograph to find details of all ingredients contained in this product. For additional generic & OTC product inquiries, please call 1-800-268-4127 , option 3 or email [email protected] . , Brand name equivalent: Afinitor® show flags of different countriesWebEverolimus C53H83NO14 CID 6442177 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, … show flash dirWebFeb 7, 2024 · Current-generation DES include everolimus-eluting stents (EES), zotarolimus-eluting stents (R-ZES]), ridaforolimus-eluting stents (RES), and two bioresorbable polymer DES (SYNERGY and Orsiro). We do not prefer one type of stent over another; each as a similar safety and efficacy profile. (See "Coronary artery stent … show flash dir flash